Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ocugen, Inc. | 151,316 | reported | 05 Jun 2025 | tx 40+2,107,205−445,473 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Jun 2025 | GRANT_AWARD | Ocugen, Inc. | 151,316 | 0.00 USD | deriv |
| 28 Jun 2024 | GRANT_AWARD | Ocugen, Inc. | 66,929 | 0.00 USD | deriv |
| 14 Jun 2023 | PURCHASE | Ocugen, Inc. | 200,278 | 0.50 USD | first after silence |
| 09 Jun 2023 | GRANT_AWARD | Ocugen, Inc. | 112,205 | 0.00 USD | deriv |
| 07 Jun 2022 | GRANT_AWARD | Ocugen, Inc. | 140,091 | 0.00 USD | deriv |
| 03 Mar 2022 | EXERCISE | Ocugen, Inc. | 49,000 | 1.83 USD | |
| 03 Mar 2022 | EXERCISE | Ocugen, Inc. | 39,000 | 0.51 USD | |
| 03 Mar 2022 | EXERCISE | Ocugen, Inc. | 39,000 | 0.00 USD | deriv |
| 03 Mar 2022 | EXERCISE | Ocugen, Inc. | 49,000 | 0.00 USD | deriv |
| 16 Nov 2021 | EXERCISE | Ocugen, Inc. | 143,820 | 2.77 USD | |
| 16 Nov 2021 | EXERCISE | Ocugen, Inc. | 1,653 | 7.56 USD | |
| 16 Nov 2021 | EXERCISE | Ocugen, Inc. | 1,653 | 0.00 USD | deriv |
| 16 Nov 2021 | EXERCISE | Ocugen, Inc. | 143,820 | 0.00 USD | deriv |
| 16 Dec 2021 | GRANT_AWARD | Ocugen, Inc. | 16,335 | 0.00 USD | deriv |
| 03 Nov 2021 | SALE | Ocugen, Inc. | 150,300 | 17.32 USD | |
| 02 Nov 2021 | SALE | Ocugen, Inc. | 149,700 | 15.75 USD | |
| 01 Jan 2021 | GRANT_AWARD | Ocugen, Inc. | 126,000 | 0.00 USD | deriv |
| 02 Jan 2020 | GRANT_AWARD | Ocugen, Inc. | 54,000 | 0.00 USD | deriv |
| 04 Dec 2019 | PURCHASE | Ocugen, Inc. | 220,000 | 0.44 USD | |
| 27 Nov 2019 | PURCHASE | Ocugen, Inc. | 270,000 | 0.37 USD | |
| 25 Nov 2019 | PURCHASE | Ocugen, Inc. | 115,000 | 0.27 USD | |
| 22 Nov 2019 | PURCHASE | Ocugen, Inc. | 80,000 | 0.28 USD | |
| 18 Nov 2019 | PURCHASE | Ocugen, Inc. | 100,000 | 0.41 USD | |
| 11 Oct 2019 | PURCHASE | Ocugen, Inc. | 4,000 | 1.48 USD | |
| 30 Sept 2019 | PURCHASE | Ocugen, Inc. | 1,358 | 2.47 USD |
1 purchase reported after at least 12 months of silence — most recent on 14 Jun 2023.